Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

Authors:

Abstract
No abstract available
Funding Information
  • Amgen
  • University of New South Wales
  • University of British Columbia
  • Ministry of Health -Singapore
  • AstraZeneca
  • Institute for Clinical Evaluative Sciences
  • Canadian Institutes of Health Research
  • National Health and Medical Research Council (1148060)

This publication has 30 references indexed in Scilit: